IBO
Price
$0.86
Change
-$0.07 (-7.53%)
Updated
Mar 10, 04:58 PM (EDT)
Capitalization
9.86M
IPA
Price
$0.38
Change
-$0.01 (-2.56%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
17.29M
Ad is loading...

IBO vs IPA

Header iconIBO vs IPA Comparison
Open Charts IBO vs IPABanner chart's image
Impact BioMedical
Price$0.86
Change-$0.07 (-7.53%)
Volume$808
Capitalization9.86M
ImmunoPrecise Antibodies
Price$0.38
Change-$0.01 (-2.56%)
Volume$13.64K
Capitalization17.29M
IBO vs IPA Comparison Chart
Loading...
IBO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IBO vs. IPA commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBO is a Hold and IPA is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (IBO: $1.44 vs. IPA: $0.35)
Brand notoriety: IBO and IPA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IBO: 44% vs. IPA: 15%
Market capitalization -- IBO: $9.86M vs. IPA: $17.29M
IBO [@Biotechnology] is valued at $9.86M. IPA’s [@Biotechnology] market capitalization is $17.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IBO’s FA Score shows that 0 FA rating(s) are green whileIPA’s FA Score has 1 green FA rating(s).

  • IBO’s FA Score: 0 green, 5 red.
  • IPA’s FA Score: 1 green, 4 red.
According to our system of comparison, both IBO and IPA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IBO’s TA Score shows that 3 TA indicator(s) are bullish while IPA’s TA Score has 3 bullish TA indicator(s).

  • IBO’s TA Score: 3 bullish, 4 bearish.
  • IPA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both IBO and IPA are a bad buy in the short-term.

Price Growth

IBO (@Biotechnology) experienced а -22.16% price change this week, while IPA (@Biotechnology) price change was -5.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPA($17.3M) has a higher market cap than IBO($9.86M). IBO YTD gains are higher at: -0.690 vs. IPA (-14.355). IBO has higher annual earnings (EBITDA): 3.14M vs. IPA (-24.28M). IPA has more cash in the bank: 3.53M vs. IBO (2.67M). IBO has less debt than IPA: IBO (8.01M) vs IPA (16.4M). IPA has higher revenues than IBO: IPA (24.1M) vs IBO (0).
IBOIPAIBO / IPA
Capitalization9.86M17.3M57%
EBITDA3.14M-24.28M-13%
Gain YTD-0.690-14.3555%
P/E Ratio8.46N/A-
Revenue024.1M-
Total Cash2.67M3.53M75%
Total Debt8.01M16.4M49%
FUNDAMENTALS RATINGS
IBO vs IPA: Fundamental Ratings
IBO
IPA
OUTLOOK RATING
1..100
8050
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
17
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9692
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
306

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IPA's Valuation (17) in the null industry is somewhat better than the same rating for IBO (50). This means that IPA’s stock grew somewhat faster than IBO’s over the last 12 months.

IPA's Profit vs Risk Rating (100) in the null industry is in the same range as IBO (100). This means that IPA’s stock grew similarly to IBO’s over the last 12 months.

IPA's SMR Rating (100) in the null industry is in the same range as IBO (100). This means that IPA’s stock grew similarly to IBO’s over the last 12 months.

IPA's Price Growth Rating (92) in the null industry is in the same range as IBO (96). This means that IPA’s stock grew similarly to IBO’s over the last 12 months.

IBO's P/E Growth Rating (95) in the null industry is in the same range as IPA (100). This means that IBO’s stock grew similarly to IPA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IBOIPA
RSI
ODDS (%)
N/A
Bullish Trend 7 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
90%
Bullish Trend 7 days ago
73%
Momentum
ODDS (%)
Bearish Trend 7 days ago
86%
N/A
MACD
ODDS (%)
Bearish Trend 7 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend about 1 month ago
81%
Declines
ODDS (%)
Bearish Trend 14 days ago
83%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 7 days ago
63%
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Ad is loading...
IBO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

IBO and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBO has been loosely correlated with BMRN. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IBO jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBO
1D Price
Change %
IBO100%
N/A
BMRN - IBO
58%
Loosely correlated
-0.72%
ITOS - IBO
46%
Loosely correlated
-2.00%
NCNA - IBO
29%
Poorly correlated
N/A
APVO - IBO
27%
Poorly correlated
-4.53%
ADAG - IBO
27%
Poorly correlated
+0.49%
More

IPA and

Correlation & Price change

A.I.dvisor tells us that IPA and ITRM have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPA and ITRM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPA
1D Price
Change %
IPA100%
+7.11%
ITRM - IPA
26%
Poorly correlated
+1.50%
TPST - IPA
25%
Poorly correlated
-0.14%
IBO - IPA
23%
Poorly correlated
N/A
AFMD - IPA
22%
Poorly correlated
-2.06%
CING - IPA
21%
Poorly correlated
-2.53%
More